- Effect of dalfampridine on gait and balance in patients with multiple sclerosis using the NeuroCom Smart Balance Master and correlation with other mobility-related measures – P 245 being presented Thursday, October 3 rd, 3:45 – 5:00pm
- Does dalfampridine increase the risk of urinary tract infections in patients with multiple sclerosis? – P 717 being presented Friday, October 4 th, 3:30 – 5:00pm
Acorda To Present New Research On AMPYRA® (dalfampridine-ER) At 29th Congress Of The European Committee For Treatment And Research In Multiple Sclerosis (ECTRIMS)
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.